ENAVATE SCIENCES GP, LLC: CMPX position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ENAVATE SCIENCES GP, LLC on CMPX, newest first. How the timeline and the estimate are built.
ENAVATE SCIENCES GP, LLC held 7,788,150 CMPX shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 7,788,150 sharesChange vs previous 13F 0 shares
4.94% of the 13F portfolio, value $17,056,049.
13F-HR 0001953107-26-000012 filed by ENAVATE SCIENCES GP, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 7,788,150 sharesChange vs previous 13F 0 shares
11.72% of the 13F portfolio, value $41,199,314.
13F-HR 0001953107-26-000008 filed by ENAVATE SCIENCES GP, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 7,788,150 sharesChange vs previous 13F 0 shares
8.25% of the 13F portfolio, value $41,822,366.
13F-HR 0001953107-26-000003 filed by ENAVATE SCIENCES GP, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 7,788,150 sharesChange vs previous 13F 0 shares
8.32% of the 13F portfolio, value $27,258,525.
13F-HR 0001953107-25-000014 filed by ENAVATE SCIENCES GP, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 7,788,150 sharesChange vs previous 13F 0 shares
11.47% of the 13F portfolio, value $20,249,190.
13F-HR 0001415889-25-021852 filed by ENAVATE SCIENCES GP, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 7,788,150 sharesChange vs previous 13F 0 shares
11.15% of the 13F portfolio, value $14,797,485.
13F-HR 0001415889-25-013132 filed by ENAVATE SCIENCES GP, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 7,788,150 sharesChange vs previous 13F not available
8.11% of the 13F portfolio, value $11,292,818.
13F-HR 0001104659-25-014094 filed by ENAVATE SCIENCES GP, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).